Stifel Financial’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-10,766
| Closed | -$18.6K | – | 3416 |
|
2022
Q4 | $18.6K | Sell |
10,766
-1,740
| -14% | -$3.01K | ﹤0.01% | 3249 |
|
2022
Q3 | $25K | Sell |
12,506
-13,722
| -52% | -$27.4K | ﹤0.01% | 3222 |
|
2022
Q2 | $19K | Sell |
26,228
-11,500
| -30% | -$8.33K | ﹤0.01% | 3282 |
|
2022
Q1 | $328K | Buy |
37,728
+7,842
| +26% | +$68.2K | ﹤0.01% | 2827 |
|
2021
Q4 | $479K | Sell |
29,886
-17,430
| -37% | -$279K | ﹤0.01% | 2612 |
|
2021
Q3 | $871K | Sell |
47,316
-1,753
| -4% | -$32.3K | ﹤0.01% | 2203 |
|
2021
Q2 | $685K | Buy |
49,069
+500
| +1% | +$6.98K | ﹤0.01% | 2389 |
|
2021
Q1 | $714K | Sell |
48,569
-419
| -0.9% | -$6.16K | ﹤0.01% | 2237 |
|
2020
Q4 | $950K | Sell |
48,988
-1,280
| -3% | -$24.8K | ﹤0.01% | 1883 |
|
2020
Q3 | $561K | Buy |
50,268
+7,481
| +17% | +$83.5K | ﹤0.01% | 2011 |
|
2020
Q2 | $579K | Sell |
42,787
-1,209
| -3% | -$16.4K | ﹤0.01% | 1941 |
|
2020
Q1 | $355K | Buy |
43,996
+13,969
| +47% | +$113K | ﹤0.01% | 2081 |
|
2019
Q4 | $289K | Buy |
30,027
+17,078
| +132% | +$164K | ﹤0.01% | 2548 |
|
2019
Q3 | $137K | Buy |
+12,949
| New | +$137K | ﹤0.01% | 2726 |
|